Avinger (AVGR) Reports Enrollment of First 50 Patients in INSIGHT Clinical Trial
Tweet Send to a Friend
Avinger, Inc. (NASDAQ: AVGR) today announced the 50th patient enrolled in its INSIGHT clinical trial. The INSIGHT trial is a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE